Literature DB >> 16968988

Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.

Ulrik Dixen1, Lasse Ravn, Christian Soeby-Rasmussen, Anders Wallin Paulsen, Jan Parner, Erik Frandsen, Gorm B Jensen.   

Abstract

BACKGROUND AND AIMS: During atrial fibrillation (AF), the renin-angiotensin-aldosterone system (RAAS) may be activated. In this study, our aim was to evaluate at a long-term follow-up visit the levels of plasma aldosterone and natriuretic peptides as markers of neurohormonal remodeling in patients with earlier, documented AF in relation to present heart rhythm, clinical data, and the left ventricular ejection fraction (LVEF). We hypothesized that increased levels of aldosterone and natriuretic peptides were significantly associated with present AF as markers of RAAS activation during the arrhythmia.
METHODS: We studied 158 patients with earlier ECG-documented AF followed by restored sinus rhythm (SR) attending a follow-up visit 2.6 years (mean) after primary inclusion.
RESULTS: At follow-up, 93 patients had SR. Heart rhythm at follow-up visit (SR/AF), plasma aldosterone, plasma N-terminal pro Brain Natriuretic Peptide (Nt-proBNP), plasma N-terminal pro Atrial Natriuretic Peptide (Nt-proANP), LVEF, medication, and clinical characteristics were recorded. Standard linear multiple regression analysis including age, sex, weight, hypertension, congestive heart failure, ischemic heart disease, present AF at follow-up, total duration of AF disease, ongoing medication, and the LVEF as explanatory variables showed that only ongoing treatment with diuretics was significantly associated (likelihood ratio test, p = 0.0057) with a raised log-transformed plasma aldosterone, although present AF at follow-up was related to a high aldosterone level (p = 0.09). For the natriuretic peptides, present AF at follow-up (p < 0.0001), age (p < 0.0001), female gender (p = 0.0047), ischemic heart disease (p = 0.0154), and ongoing treatment with sotalol (p = 0.0003) were all independently associated with high log-transformed plasma Nt-proANP. Likewise, present AF at follow-up (p = 0.0008) as well as age (p < 0.0001) were associated with high log-transformed plasma Nt-proBNP.
CONCLUSIONS: In patients with earlier AF, AF at long-term follow-up visit was independently associated with raised levels of Nt-proANP and Nt-proBNP and to some extent with plasma aldosterone indicating neurohormonal activation during arrhythmia. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16968988     DOI: 10.1159/000095671

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  15 in total

Review 1.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

Review 2.  Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

Authors:  Teresa M Seccia; Brasilina Caroccia; Gail K Adler; Giuseppe Maiolino; Maurizio Cesari; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-04       Impact factor: 10.190

Review 3.  Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.

Authors:  Adedotun A Ogunsua; Amir Y Shaikh; Mohamed Ahmed; David D McManus
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

Review 4.  Arterial Hypertension, Aldosterone, and Atrial Fibrillation.

Authors:  Teresa M Seccia; Brasilina Caroccia; Giuseppe Maiolino; Maurizio Cesari; Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2019-11-18       Impact factor: 5.369

5.  Association between aldosterone synthase (CYP11B2) -344C/T polymorphism and atrial fibrillation among Han and Kazak residents of the Xinjiang region.

Authors:  Wu-Hong Lu; Maerjiaen Bayike; Ji-Wen Liu; Shanshan Wang; Xiang Xie; Yu-Chun Yang; Fen Liu; Na Li; Zhi-Qiang Liu; Peng-Yi He
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Prolongation of PR interval is associated with endothelial dysfunction and activation of vascular repair in high-risk cardiovascular patients.

Authors:  Yap-Hang Chan; Chung-Wah Siu; Kai-Hang Yiu; Yuen-Fung Yiu; Kui-Kai Lau; Tai-Hing Lam; Chu-Pak Lau; Hung-Fat Tse
Journal:  J Interv Card Electrophysiol       Date:  2013-02-07       Impact factor: 1.900

7.  Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing.

Authors:  J Zhao; J Li; W Li; Y Li; H Shan; Y Gong; B Yang
Journal:  Br J Pharmacol       Date:  2010-01-15       Impact factor: 8.739

Review 8.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

9.  The effects of radio-frequency ablation on blood pressure control in patients with atrial fibrillation and hypertension.

Authors:  Alexies Ramirez; Christina F Pacchia; Natalie A Sanders; Stephen L Wasmund; Mohamed H Hamdan
Journal:  J Interv Card Electrophysiol       Date:  2012-08-11       Impact factor: 1.900

Review 10.  Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.

Authors:  Da-Rong Pu; Jun R Chiong; Qi-chang Zhou
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.